ABOUT G2MC
Overview
The Global Genomic Medicine Consortium (G2MC) is creating a community of global leaders dedicated to advancing genomic medicine implementation in clinical care.
G2MC is identifying opportunities to foster global collaboration to demonstrate value and the effective use of genomics in medicine. The G2MC was started as an ‘action collaborative’ in the United States National Academies of Medicine and also was supported by the National Human Genome Research Institute of the NIH. Now as an independent not-for-profit charitable organization, it seeks to improve global health by catalyzing the implementation of genomic tools and knowledge into health care delivery globally.
Our Mission
To leverage and nurture global expertise, create practical, real world solutions, and disseminate knowledge for implementing genomic medicine in diverse settings around the world.
Our Vision
Genomic Medicine for everyone.
Strategic Plan
View our values, guiding principles, and strategic directions for the next five years.
What We Do
G2MC focuses its energy and resources on programs and initiatives that connect stakeholders, encourage exchange, contribute evidence, and share solutions.
- Connect: Reduce barriers for collaboration and serve as a global resource for genomic medicine expertise from many disciplines (clinical, technological, data science, education, and policy).
- Exchange: Encourage bi-directional sharing and support among members of the G2MC community regardless of their career stage in order to nurture the workforce of tomorrow.
- Contribute: Provide a conduit for development, execution, and dissemination of opportunities for global genomic medicine implementation projects. Build clearinghouse and knowledge base for cross-discipline genomic medicine implementation expertise (e.g., from clinical, technological, data science, education, and policy).
- Share: Disseminate best practices for genomic medicine implementation to policymakers and practitioners.
Diversity, Inclusion, and Equity
“We are committed to diversity, inclusion and equity in our mission. The G2MC is a supportive environment in which colleagues from diverse backgrounds and demographics can excel.
We see our community as equal in terms of stature and opportunities to contribute. We bridge language barriers, increase opportunities for funding, partnerships, and participation from all of the members and stakeholders we serve.”
Our History
The Global Genomic Medicine Consortium (G2MC), originally the Global Genomic Medicine Collaborative, was established as a not-for-profit organization based in the United States in 2016 with the goal of enabling the implementation of genomic medicine worldwide in order to improve individual and population health. The impetus for the G2MC grew from a gathering of 90 leaders in genomic medicine from the U.S. and 25 other countries in January 2014. Similar to what was seen in a 2011 gathering of national leaders in genomic medicine, it was clear that many nations and organizations around the globe were mounting independent and siloed efforts to bring genome-based technologies into healthcare delivery systems across diverse populations, demographics, and economies. Founded by Dr. Geoffrey S. Ginsburg, G2MC was formed to lead and coordinate efforts with international organizations to advance the implementation of genomic medicine by leveraging expertise and reducing duplication.
Read more about the formation of G2MC in the following publication:
Ginsburg, G. S. (2019). A global collaborative to advance genomic medicine. The American Journal of Human Genetics, 104(3), 407-409. https://doi.org/10.1016/j.ajhg.2019.02.010
